Recombinetics

Recombinetics is a private biotechnology company dedicated to solving the world's toughest challenges through gene editing. By developing and deploying safe and effective tools for these applications, it aims to transform the world across the entire agricultural market. Utilizing breakthrough technologies to improve and accelerate preclinical testing, thereby delivering safer and more effective therapies. Leading advancements in organ transplantation and regenerative medicine to enhance patient outcomes.